Health & Wellness
09/30/2026 · Schley & Sumter Region
Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial
Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.
UK Study Investigates Personalized Pain Management for Endometriosis
A new UK study will explore whether individualized pain management plans can improve quality of life for women with endometriosis. The research, backed by £2.3 million in funding, involves multiple institutions across the country.
10/01/2026
Dementia Patient Medication Use: A Michigan Case Study
A Michigan woman's case highlights family and guardian choices concerning sedating medications for agitated dementia patients. These medications are used in long-term care facilities. Federal initiatives aim to reduce their application.
09/30/2026
HHS Report on Gender-Affirming Care Draws Scrutiny
A recent report from a federal health agency is prompting discussion regarding established healthcare models for transgender individuals. Critics characterize the report's framing of transgender identity in specific ways.
09/30/2026
Measles Cases Reported in Multiple States, Exposure Sites Include Travel and Public Events
Measles outbreaks have appeared in Pennsylvania, Ohio, and New York. Health officials have identified potential exposure locations, including public transportation and sports events. Individuals planning travel should consult health guidelines.
09/30/2026
Eli Lilly Drug Retatrutide Shows Weight Loss in Type 2 Diabetes Trial
Eli Lilly's experimental drug retatrutide led to notable weight reduction in individuals with Type 2 diabetes, according to new trial results. Participants in the study, published in The Lancet, experienced an average loss of up to 60 pounds.
09/30/2026
More Health & Wellness
Sponsored
Advertisement
Upcoming Events
View allOCT
01
Georgia DOT Bicycle & Pedestrian Program Initiatives
7:00 PM - Free
OCT
03
Fort Valley St. at Central St. (OH)
17:00
OCT
03
Mercer at VMI
17:30
Announcements
View allWater & Sewer Department
W A T E R & S E W E R D E P A R T M E N T The Water Department is responsible for providing water services to all customers within in the corporate limits of the City of Ellaville and areas immediately adjacent to the city limits. The department provides services to approximately 975 water customers. Download Water and Sewer Rates Download Water Quality Report Billing Questions City Hall (229) 937-2207 8:00 a.m. - 5:00 p.m. Mon-Fri Closed 12:00 p.m. - 1:00 p.m. Power Outages and Emergency Services Daytime Hours (229) 937-2207 6:00 a.m. - 5:00 p.m. Mon-Thur Closed Friday Central Dispatch (229) 937-9011 After 5:00 p.m., Holidays & Weekends
Columbus Day Holiday – Office Closed Monday, October 12
Columbus Day Holiday – Office Closed Monday, October 12 October 12 is a state holiday. We will reopen on Tuesday.
Logo & Brand Guidelines - Georgia DOT
Logo & Brand Guidelines - Georgia DOT Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. Turn on more accessible mode Turn off more accessible mode Skip Ribbon Commands Skip to main content Turn off Animations Turn on Animations Sign In GDOTCurrently selected logoguidelines Logo & Brand Guidelines - Georgia DOT Recent GDOTCurrently selected Logo & Brand Guidelines Georgia DOT's logo and branding materials are available for download. Branding Standards & Guidelines Download GDOT Logo Download GDOT Icons Download Questions & Comments Should you have any questions about the use of Georgia DOT's logo or branding, please contact the following: Office of Strategic Communications (404) 631-1834 Email
Advertisement
Advertisement